CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Carbidopa, levodopa and entacapone

Last Updated: April 15, 2008
Result type: Reports
Project Number: S0131
Product Line: Common Drug Review

Generic Name: Carbidopa, levodopa and entacapone

Brand Name: Stalevo

Manufacturer: Novartis Pharmaceuticals Canada Inc.

Indications: Parkinsons Disease

Submission Type: New

Project Status: Complete

Date Recommendation Issued: October 16, 2008

Recommendation Type: List in a similar manner